Left Atrial Dysfunction in Apical Hypertrophic Cardiomyopathy: Assessed by Cardiovascular Magnetic Resonance

Yingxia Yang1,2, Minjie Lu3, Xuechun Guan1

  • 1Department of Radiology, The First Affiliated Hospital of Guangxi Medical University.

PubMed

Insights

Apical hypertrophic cardiomyopathy (AHCM) impairs left atrial (LA) reservoir and conduit function in both typical and subclinical patients. Cardiovascular magnetic resonance feature tracking (CMR-FT) effectively quantifies these functional deficits.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Apical hypertrophic cardiomyopathy (AHCM) is a distinct form of hypertrophic cardiomyopathy.
  • Left atrial (LA) function plays a crucial role in cardiovascular health.
  • Assessing LA function in AHCM can provide insights into disease mechanisms and progression.

Purpose of the Study:

  • To evaluate left atrial (LA) function in patients with apical hypertrophic cardiomyopathy (AHCM) using cardiovascular magnetic resonance feature tracking (CMR-FT).
  • To compare LA function between typical AHCM (TAHCM), subclinical AHCM (SAHCM), and healthy controls.

Main Methods:

  • Retrospective analysis of 30 TAHCM patients, 23 SAHCM patients, and 32 healthy controls who underwent CMR.
  • Quantification of LA reservoir, conduit, and contractile function using volumetric and CMR-FT derived strain and strain rate (SR) parameters.
  • Analysis of 2-chamber and 4-chamber cine imaging.

Main Results:

  • Both TAHCM and SAHCM patients exhibited impaired LA reservoir and conduit function compared to controls.
  • LA reservoir and conduit strain were significantly associated with left ventricular mass index and maximal wall thickness.
  • While active emptying fraction and strain were preserved, TAHCM patients showed the lowest active SR.

Conclusions:

  • Left atrial (LA) reservoir and conduit functions are predominantly impaired in both subclinical and typical apical hypertrophic cardiomyopathy (AHCM) patients.
  • CMR-FT is a valuable tool for assessing LA functional deficits in AHCM.
  • These findings highlight the impact of AHCM on atrial function.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
33
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
25